Process mapping strategies to prevent subcutaneous implantable cardioverter‐defibrillator infections-Reference-Cited by-同舟云学术

Process mapping strategies to prevent subcutaneous implantable cardioverter‐defibrillator infections

Published:2022-06-09 Issue:7 Volume:33 Page:1628-1635
ISSN:1045-3873
Container-title:Journal of Cardiovascular Electrophysiology
language:en
Short-container-title:Cardiovasc electrophysiol

Author:

Weiss Raul¹^ORCID,Mark George E.²,El‐Chami Mikhael F.³^ORCID,Biffi Mauro⁴,Probst Vincent⁵,Lambiase Pier D.⁶,Miller Marc A.⁷^ORCID,McClernon Timothy⁸,Hansen Linda K.⁹,Knight Bradley P.¹⁰,Baddour Larry M.¹¹¹²,

Affiliation:

1. Department of Internal Medicine, Division of Cardiovascular Medicine The Ohio State University Wexner Medical Center Columbus Ohio USA

2. Department of Cardiology Cooper University Hospital Camden New Jersey USA

3. Division of Cardiology, Section of Electrophysiology Emory University Hospital Atlanta Georgia USA

4. University of Bologna, and Azienda Ospedaliera di Bologna Bologna Italy

5. L'Institut du Thorax Cardiologic Department and Reference Center for Hereditary Arrhythmic Diseases Nantes France

6. UCL Institute of Cardiovascular Science, and Barts Heart Center London UK

7. Icahn School of Medicine at Mount Sinai Mount Sinai Hospital New York New York USA

8. People Architects Inc. Minneapolis Minnesota USA

9. Boston Scientific St. Paul Minnesota USA

10. Medical Director of Cardiac Electrophysiology, Center for Heart Rhythm Disorders Bluhm Cardiovascular Institute Northwestern Memorial Hospital Chicago Illinois USA

11. Department of Medicine, Division of Infectious Diseases Mayo Clinic College of Medicine and Science Rochester Minnesota USA

12. Department of Cardiovascular Disease Mayo Clinic College of Medicine and Science Rochester Minnesota USA

Funder

Boston Scientific Corporation

Publisher

Wiley

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jce.15566

Reference37 articles.

1. An Entirely Subcutaneous Implantable Cardioverter–Defibrillator

2. Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator

3. Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator

4. Subcutaneous or Transvenous Defibrillator Therapy

5. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society;Al‐Khatib SM;Heart Rhythm,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complexation of Terpenes for the Production of New Antimicrobial and Antibiofilm Molecules and Their Encapsulation in Order to Improve Their Activities;Applied Sciences;2023-08-31